SAN FRANCISCO--(BUSINESS WIRE)--Presidio Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing small molecule compounds for the treatment of HIV-1, HCV and other chronic viral infections, announces today that Marcus Conant, MD has joined the company as its Chief Medical Officer, and Antoun Nabhan, JD has joined as Chief Financial Officer.
